Time to diagnosis and stage of symptomatic colorectal cancer determined by three different sources of information: A population based retrospective study
Resumen: Background
Survival rates from colorectal cancer (CRC) are highly variable in Europe. This variability could potentially be explained by differences in healthcare system delays in diagnosis. However, even when such delays are reduced, the relationship of the diagnostic interval (time from presentation with symptoms to diagnosis) with outcome is uncertain.
Methods
A total of 795 patients with CRC from 5 regions of Spain were retrospectively examined in this population-based multicenter study. Consecutive incident cases of CRC were identified from pathology services. The total diagnostic interval (TDI) was defined as the time from the first presentation with symptoms to diagnosis based on 3 different sources of information: (i) patient-recorded data (PR-TDI) by interview, (ii) hospital-recorded data (HR-TDI), and (iii) general practitioner-recorded data (GPR-TDI). Concordance correlation coefficients (CCCs) were used to estimate the agreement of 3 different TDIs. The TDIs of patients with different stages of CRC were also compared using the Kruskal-Wallis test.
Results
The median TDI was 131 days based on patient interview data, 91 days based on HR data, and 111 days based on GPR data. Overall, the agreement of these TDIs was poor (CCCPRvsHR = 0.399, CCCPRvsGPR = 0.518, CCCHRvsGPR = 0.383). Univariate analysis indicated that the TDI was greater in those with less advanced CRC for all 3 methods of calculation, but this association was only statistically significant for the HR-TDI (p = 0.021).
Conclusion
There is no evidence that patients with more advanced CRC have longer TDIs. In fact, we found an inverse relationship between the TDI and CRC stage, an example of the “waiting time paradox”. This association may likely be due to the presence of unmeasured confounders as the stage when symptoms appear or the tumour aggressiveness.

Idioma: Inglés
DOI: 10.1016/j.canep.2016.10.021
Año: 2017
Publicado en: Cancer Epidemiology 47 (2017), 48-55
ISSN: 1877-7821

Factor impacto JCR: 2.888 (2017)
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 42 / 179 = 0.235 (2017) - Q1 - T1
Categ. JCR: ONCOLOGY rank: 129 / 223 = 0.578 (2017) - Q3 - T2

Factor impacto SCIMAGO: 1.552 - Oncology (Q1) - Cancer Research (Q2) - Epidemiology (Q2)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI050700
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI050787
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI052141
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI052273
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/PI052692
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-RETCI/RD12-0005-0011
Financiación: info:eu-repo/grantAgreement/ES/ISCIII-RETCI/G03-170
Tipo y forma: Artículo (PostPrint)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, no puede difundir el material modificado.


Exportado de SIDERAL (2025-01-20-14:53:10)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Medicina



 Registro creado el 2025-01-20, última modificación el 2025-01-20


Postprint:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)